TABLE 2.

Confirmed Oncosuppressor miRNAs in Prostate Cancer ^a .

Stilbene	miRNA	Identified Target	Associated information or Events	References
No treatment	miR-654-5p	AR	PSA, LNCaP cell proliferation	Ostling et al. (2011)
No treatment	miR-149	AR	CRCP 22-Rv1 cells	Zhao et al. (2021)
		P13K/Akt1
No treatment	miR-149-5p	RGS17	Viability, proliferation, migration of 22Rv1 and C4-2 cells , high in prostate cancer tissues	Ma et al. (2021)
No treatment	miR-1231	EGFR	Cell proliferation, migration, invasion in DU145, 22Rv1, PC3, and VCaP, high in prostate cancer tissues	Wang Y et al. (2020)
No treatment	miR-939-3p	BCYRN1/HDAC11	Cell proliferation,	Huo et al. (2020)
			Decreased in prostate cancer tissues vs. normal
No treatment	miR-1908	SRM	22Rv1 cells, high in prostate cancer tissues	Urabe et al. (2020)
No treatment	miR-1915-3p		Upregulation was linked to recurrence-free survival	Ali et al. (2021)
			Independent prognostic marker

^aThese miRNAs are putative stilbene-regulated oncosuppressor miRs previously identified by Dhar et al., 2011.